Cannabinoid API Solutions
Blue Bell, US · Founded 2022 · Delaware LLC
Cannabinoid API Solutions supplies hemp-derived cannabinoid active pharmaceutical ingredients (APIs), such as CBD, for use in pharmaceutical applications. It serves companies developing cannabinoid-based pharmaceutical products.
Founders & leadership
HB
Hugh BowermanManager
Reported raises · per SEC filings
Form D private placements$2.2M disclosed across 1 round · 2022
▶$2.2MraisedSep 2022 · 10 investors · PharmaceuticalsRule 506(b)
▶$2.2MraisedSep 2022 · 10 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Hugh BowermanExecutive Officer
- Offering amount
- $2.2M
- Amount sold
- $2.2M
- First sale
- Aug 2022
- Incorporated
- Limited Liability Company, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Cannabinoid API Solutions do?
- Cannabinoid API Solutions supplies hemp-derived cannabinoid active pharmaceutical ingredients (APIs), such as CBD, for use in pharmaceutical applications. It serves companies developing cannabinoid-based pharmaceutical products.
- How much funding has Cannabinoid API Solutions raised?
- Cannabinoid API Solutions has disclosed $2.2M raised across 1 round.
- Where is Cannabinoid API Solutions headquartered?
- Cannabinoid API Solutions is headquartered in Blue Bell, US.